HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Black Women For Wellness Study Links Hair Care To Endemic Health Issues

This article was originally published in The Rose Sheet

Executive Summary

Health problems with marked prevalence among salon professionals and Black females may reflect toxic exposure to chemicals used in hair care, BWW suggests. The NGO sees improved education and regulatory reform as potential answers, but its report also highlights the premium that pros and their clients put on product efficacy, which likely factors in companies' safety assessments as they weigh benefits against risks.

You may also be interested in...



Brazilian Blowout Manufacturer Required To Label, Warn Users

Brazilian Blowout parent company GIB LLC has settled a class action suit in California that directs the firm to pay more than $4 million to class members and properly label products with all ingredients and warnings about potential health risks.

PCPC Expects Rapid-Fire Implementing Measures Following China’s CSAR Drop

China’s newly adopted Cosmetics Supervision and Administration Regulation could mean less animal testing and speedier approval of new ingredients, according to Francine Lamoriello of the Personal Care Products Council. Coming implementing regulations, standards and guidances should help to provide needed clarity, she says.

GermBloc Hand-Sanitizer Class Action Takes Aim At 99.99% Germ-Killing Claim

Like other hand sanitizer manufacturers, WillSpeed Technology claims its GermBloc “kills 99.99% of germs.” Plaintiffs in a proposed class action filed in Massachusetts federal court allege the claim “grossly overstates” the product’s efficacy, deceiving consumers and endangering them with false confidence.

Topics

UsernamePublicRestriction

Register

SC100339

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel